Ciprofloxacin and acute aortic valve damage-Reference-Cited by-同舟云学术

Ciprofloxacin and acute aortic valve damage

Published:2018-12 Issue: Volume:121 Page:35
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

Schjøtt Jan,Messner Torbjörn

Publisher

Elsevier BV

Subject

General Medicine

Reference10 articles.

1. Health Canada. Summary safety review – fluoroquinolones – assessing the potential risk of persistent and disabling side effects. http://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/fluoroquinolones2-eng.php/ [accessed June, 2018].

2. Tendon injury and fluoroquinolone use: a systematic review;Stephenson;Drug Saf,2013

3. Risk of aortic dissection and aortic aneurysm in patients taking oral fluoroquinolone;Lee;JAMA Intern Med,2015

4. Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study;Daneman;BMJ Open,2015

5. Type I and type III collagen synthesis and composition in the valve matrix in aortic valve stenosis;Eriksen;Atherosclerosis,2006

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of fluoroquinolones and the risk of aortic and mitral regurgitation: A nationwide case-crossover study;PLOS ONE;2024-07-24

2. Association Between Use of Fluoroquinolones and Risk of Mitral or Aortic Valve Regurgitation: A Nationwide Cohort Study;Clinical Pharmacology & Therapeutics;2023-11-13

3. Long-term Cardiovascular Adverse Events Induced by Fluoroquinolones: A Retrospective Case–control Study;Journal of Cardiovascular Pharmacology;2023-11

4. Oral fluoroquinolones and risk of aortic or mitral regurgitation: a nationwide nested case-control study;European Heart Journal;2021-07-10

5. Fluoroquinolone-Induced Aortic Injury;Safety and Risk of Pharmacotherapy;2021-07-01